NeuroScientific Biopharmaceuticals Ltd
NSB.AX ✗ NOT COMPLIANTFree checks used up today ☆ Track — members
ASX
·
Healthcare
·
Biotechnology & Medical Research
·
Last Close
$0.04
▲ +1.72%
Price charts are for members
Interactive price history from intraday to 5 years, on every stock and ETF.
See plans
Key Metrics
P/E Ratio
N/A
FWD: N/A
Market Cap
$16.00M
Micro Cap
Div Yield
0.00%
Annual dividend
EPS Growth
N/A
YoY
RSI (14)
47.62
Momentum
Beta
1.91
vs Market
52W High
$0.13
65.75% below
52W Low
$0.04
8.22% above
Volume
22.12K
Avg 115.44K
P/B
1.55
Price-to-book
ROE
N/A
Return on equity
Free Float
54.79%
Public shares
Historical Returns
5D
-4.84%
1M
-4.84%
3M
-16.90%
6M
-39.18%
YTD
-46.36%
1Y
-63.13%
3Y
+9.10%
5Y
-85.25%
Financials & Valuation
TTM · Annual
| Total Revenue | $435.48K |
| Net Income | $-3,247,187.00 |
| Revenue Growth (YoY) | +172.22% |
| Gross Margin | 100.00% |
| Operating Margin | -711.56% |
| Net Profit Margin | -745.66% |
| ROE | N/A |
| ROA · ROIC | -29.20% · N/A |
| P/E Ratio | N/A |
| Forward P/E (FY1) | N/A |
| PEG Ratio | N/A |
| P/S | 31.62 |
| P/B | 1.55 |
| P/FCF | N/A |
| EPS Growth | N/A |
| Outstanding Shares | 389.72M |
Technical Indicators
| 50-Day SMA | $0.04 |
| 200-Day SMA | $0.06 |
| RSI (14) | 47.62 |
| Beta | 1.91 |
| 52-Week High | $0.13 |
| 52-Week Low | $0.04 |
| Volume Today | 22.12K |
| Avg Daily Volume (30D) | 115.44K |
| Relative Volume | 0.19x |
| Volatility (10D) | 61.54 |
| Volatility (30D) | 64.94 |
| Free Float | 54.79% |
